REALE, MARIA LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.233
EU - Europa 734
AS - Asia 372
SA - Sud America 15
AF - Africa 9
OC - Oceania 8
Totale 2.371
Nazione #
US - Stati Uniti d'America 1.212
IT - Italia 256
CN - Cina 140
IE - Irlanda 133
SE - Svezia 116
GB - Regno Unito 57
VN - Vietnam 53
UA - Ucraina 33
SG - Singapore 31
JP - Giappone 27
HK - Hong Kong 26
DE - Germania 22
FR - Francia 22
IN - India 20
CA - Canada 17
PL - Polonia 16
KR - Corea 15
BE - Belgio 13
ES - Italia 13
JO - Giordania 12
AT - Austria 8
IR - Iran 8
TR - Turchia 8
AU - Australia 7
CH - Svizzera 7
PK - Pakistan 7
RU - Federazione Russa 7
TW - Taiwan 6
BR - Brasile 5
GR - Grecia 5
HR - Croazia 5
NL - Olanda 5
CO - Colombia 4
EG - Egitto 4
FI - Finlandia 4
RO - Romania 4
EC - Ecuador 3
ID - Indonesia 3
PS - Palestinian Territory 3
TN - Tunisia 3
DK - Danimarca 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
IL - Israele 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
Totale 2.371
Città #
Chandler 237
Dublin 132
Fairfield 100
Nyköping 66
Ashburn 55
Woodbridge 49
Torino 43
Turin 43
Medford 37
Seattle 36
Wilmington 35
Cambridge 34
Beijing 33
Houston 33
Princeton 30
Redwood City 28
Dong Ket 25
Ann Arbor 23
Hangzhou 22
New York 20
Central 17
Fremont 15
Dearborn 13
Jacksonville 13
Milan 13
Singapore 13
Amman 12
Pisa 12
Seoul 12
Hebei 10
Nanjing 10
San Diego 10
Boston 9
Tokyo 9
Piemonte 8
Rome 8
Vienna 8
Warsaw 8
London 7
Chengdu 6
Karachi 6
Kraków 6
Brussels 5
Hefei 5
Jinan 5
Los Angeles 5
Manchester 5
Castellaneta 4
Central District 4
Helsinki 4
Kingston upon Thames 4
Medellín 4
Paris 4
Preston 4
Pune 4
San Jose 4
Shanghai 4
Taipei 4
Tehran 4
Toronto 4
Vancouver 4
Adana 3
Amsterdam 3
Biella 3
Delhi 3
Falls Church 3
Guangzhou 3
Hoffman 3
Istanbul 3
Kulmbach 3
Mumbai 3
Namur 3
Norwalk 3
Parma 3
Ramallah 3
Redmond 3
River Edge 3
Rochester 3
San Francisco 3
Thai Nguyen 3
Verona 3
Wakagi 3
Washington 3
Zibo 3
Zurich 3
Bayonne 2
Bhilai 2
Boardman 2
Bologna 2
Bolzano 2
Boquete 2
Buffalo 2
Bury 2
Cagliari 2
Cairo 2
Catania 2
Cergy 2
Chicago 2
Collegeville 2
Concord 2
Totale 1.489
Nome #
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma 191
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 154
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018 153
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review 122
Quality of life in patients with lung cancer: the way forward 120
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients 107
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival 106
SELECTing adjuvant treatment in early stage epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer 100
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018 91
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit 87
Osimertinib-induced Cardiac Dysfunction in EGFRMutated Lung Cancer: A Case Series of Five Patients 84
LATITUDE and other coordinates in quality of life of prostate cancer patients 79
Clinical and molecular features of epidermal growth factor receptor (Egfr) mutation positive non‐small‐cell lung cancer (nsclc) patients treated with tyrosine kinase inhibitors (tkis): Predictive and prognostic role of co‐mutations 70
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era 68
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave 67
Dealing with NSCLC EGFR mutation testing and treatment: a comprehensive review with an Italian real-world perspective 63
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients 61
Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon? 61
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics 57
68 Ga-PSMA Uptake in Fibrous Dysplasia 56
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 55
Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: Are we actually ready? 55
Repositioning PARP inhibitors in the treatment of thoracic malignancies 55
An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease 52
Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center 47
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 44
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features 43
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon 40
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements 35
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer 32
Resistance to anaplastic lymphoma kinase inhibitors: Knowing the enemy is half the battle won 32
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients 29
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center 24
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study 5
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program 3
The KEY for chemo-immunotherapy combination: Taking NOTEs from squamous cell lung cancer 3
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 1
Totale 2.452
Categoria #
all - tutte 8.183
article - articoli 0
book - libri 0
conference - conferenze 215
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 0 18 10
2019/2020187 5 7 4 14 10 20 23 18 28 22 20 16
2020/2021434 17 16 26 22 33 21 22 32 59 51 33 102
2021/2022605 46 33 37 27 36 28 41 40 21 66 144 86
2022/2023814 66 103 38 79 66 173 47 66 68 21 56 31
2023/2024357 69 58 20 54 17 48 8 25 10 45 3 0
Totale 2.452